Volume 10, Number 5—May 2004
Multidrug-resistant Tuberculosis in Central Asia
|Total||Resistant (%)||Total||Resistant (%)||Total||Resistant (%)|
|Prothionamide||106||7 (7)||107||11 (10)||57||9 (16)|
|Capreomycin||88||1 (1)||101||1 (1)||56||1 (2)|
|Ofloxacin||88||2 (2)||101||4 (4)||56||1 (2)|
|Prothionamide||105||1 (1)||98||4 (4)||22||2 (9)|
aAll strains were tested for prothionamide; a representative subset of these were tested for both capreomycin and ofloxacin.
bMDR-TB, multidrug-resistant tuberculosis.
Page created: February 22, 2011
Page updated: February 22, 2011
Page reviewed: February 22, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.